Synlab AG

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

D8T7KY106
SEDOL

BMWPXW9
CIK

N/A

synlab.com
LEI: 984500883BA5AQ14C037
FIGI: BBG00ZXRLR30
SYAB

Synlab AG
GICS: 35102015 · Sector: - · Sub-Sector: -
NAME
Synlab AG
ISIN
DE000A2TSL71
TICKER
SYAB
MIC
XETR
REUTERS
SYAB.DE
BLOOMBERG
SYAB GR
EN 728x90
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Wed, 30.10.2024

Cinven to Acquire Elliott’s Stake in SYNLAB AG, Squeeze-Out to Follow Elliott to remain indirect minority shareholder in SYNLAB The Management Board of SYNLAB AG (“SYNLAB”) has been informed that international private equity firm Cinven has reached an agreement with funds advised by Elliott Advisors (UK) Limited (“Elliott”). Under this agreement,...
Tue, 17.09.2024

Cinven to sell minority stake in SYNLAB to strategic investor Labcorp International private equity firm, Cinven, has reached an agreement to sell an indirect minority stake in SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, to strategic investor Labcorp. Labcorp is a global leader of innovative and comprehensive la...
Tue, 17.09.2024

Cinven to sell minority stake in SYNLAB to strategic investor Labcorp International private equity firm, Cinven, has reached an agreement to sell an indirect minority stake in SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, to strategic investor Labcorp. Labcorp is a global leader of innovative and comprehensive la...
Tue, 04.06.2024

Cybersecurity Incident at Synnovis in UK SYNLAB AG ("SYNLAB", FSE: SYAB) confirms that Synnovis, a partnership between two London-based hospital Trusts and SYNLAB UK & Ireland, was the victim of a cyber-attack on 3 June 2024. A taskforce of IT experts from Synnovis and the National Health Service in UK (NHS England) is working diligently to fu...
Fri, 31.05.2024

SYNLAB AG (“SYNLAB”; FSE: SYAB) has today signed a delisting agreement (“Delisting Agreement”) with Ephios Bidco GmbH, a subsidiary of Ephios Luxembourg S.à r.l., both holding companies controlled by investment funds advised by Cinven Limited. Concurrently, Ephios BidCo GmbH announced its decision to make a public delisting acquisition offer to the...
Fri, 31.05.2024

SYNLAB AG (“SYNLAB”; FSE: SYAB) has today signed a delisting agreement (“Delisting Agreement”) with Ephios Bidco GmbH, a subsidiary of Ephios Luxembourg S.à r.l., both holding companies controlled by investment funds advised by Cinven Limited. Concurrently, Ephios BidCo GmbH announced its decision to make a public delisting acquisition offer to the...
Fri, 31.05.2024

EQS-WpÜG: Ephios Bidco GmbH / Tender Offer Tender Offer / Target company: SYNLAB AG; Bidder: Ephios Bidco GmbH 31.05.2024 / 08:35 CET/CEST Dissemination of an announcement according to the German Securities Acquisition and Takeover Act (WpÜG), transmitted by EQS News - a service of EQS Group AG. The bidder is solely responsible for the c...
Wed, 08.05.2024

SYNLAB delivers strong performance in Q1 2024   Revenue at €682 million Strong underlying organic growth at 3.9% (Q1 2023: 10.0%); 5.2% adjusted for working days Adjusted EBITDA at €123 million (increased by 4% compared to Q1 2023) Strong Adjusted EBITDA margin at 18.0% (Q1 2023: 16.9%), at the upper end of the guided range for FY 2024 of 17-1...
Wed, 08.05.2024

SYNLAB delivers strong performance in Q1 2024   Revenue at €682 million Strong underlying organic growth at 3.9% (Q1 2023: 10.0%); 5.2% adjusted for working days Adjusted EBITDA at €123 million (increased by 4% compared to Q1 2023) Strong Adjusted EBITDA margin at 18.0% (Q1 2023: 16.9%), at the upper end of the guided range for FY 2024 of 17-1...
Tue, 30.04.2024

SYNLAB Italy has restored operations after cyber-attack   SYNLAB Italy has restored operations and will gradually resume all services for patients and customers. Due to a cyber-attack, SYNLAB had suspended operations in Italy as a precautionary measure. SYNLAB Group confirms no impact on operations in other countries.   SYNLAB AG ("SYNLAB", FSE...
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements